Lawsuits to receive free medication: Federal expenditures for the Brazilian Public Health System (SUS) between 2011-2014

Detalhes bibliográficos
Autor(a) principal: Nogueira, Karina Pires
Data de Publicação: 2017
Outros Autores: Camargo, Erika Barbosa
Tipo de documento: Artigo
Idioma: por
Título da fonte: Cadernos Ibero-Americanos de Direito Sanitário (Online)
Texto Completo: https://www.cadernos.prodisa.fiocruz.br/index.php/cadernos/article/view/387
Resumo: Objective To analyze Federal expenditures for the Brazilian public health system with drugs obtained through lawsuits between the years 2011-2014. Methods: cross-sectional study, with descriptive and analytical characteristics. Data collected from the DW / COMPRASNET platform. Results: In total 12,578 lawsuits were identified at the federal level and 15 drugs with the highest acquisition value were extracted. Of these, seven drugs corresponded to US$ 452.644.065.68 million dollars of the federal budget, which represented 87% of the total expenditure of the actions studied. Of the 15 drugs / year studied, 14.28% (n = 4) were registered at the National Brazilian Surveillance Agency (ANVISA), were incorporated by the National Commission for the Incorporation of Technologies in SUS (CONITEC) and were part of the List of essential drugs (RENAME); 46.42% (n = 13) were registered with ANVISA, but not incorporated by CONITEC and not members of RENAME; 3.57% (n = 1) registered in ANVISA, incorporated by CONITEC and non-RENAME members and 35.71% (n = 10) without ANVISA registration, not incorporated by CONITEC and not RENAME members. Conclusion: With the Lawsuits to receive free medication, the acquisitions are carried out without planning or establishing minimum criteria, may compromise SUS sustainability.
id FIOCRUZ-3_55e25ab33895dc7a8d41e54decdf490d
oai_identifier_str oai:ojs.cadernos.prodisa.fiocruz.br:article/387
network_acronym_str FIOCRUZ-3
network_name_str Cadernos Ibero-Americanos de Direito Sanitário (Online)
repository_id_str
spelling Lawsuits to receive free medication: Federal expenditures for the Brazilian Public Health System (SUS) between 2011-2014Judicialización de la salud: gastos Federales para el Sistema Público de Salud entre 2011-2014Judicialização da saúde: gastos Federais para o Sistema Único de Saúde (SUS) entre 2011-2014JudicializaçãoDecisões judiciaisDireito à saúdeJudicializationJudge DecisionsRight to HealthJudicializaciónDecisiones judicialesDerecho a la saludObjective To analyze Federal expenditures for the Brazilian public health system with drugs obtained through lawsuits between the years 2011-2014. Methods: cross-sectional study, with descriptive and analytical characteristics. Data collected from the DW / COMPRASNET platform. Results: In total 12,578 lawsuits were identified at the federal level and 15 drugs with the highest acquisition value were extracted. Of these, seven drugs corresponded to US$ 452.644.065.68 million dollars of the federal budget, which represented 87% of the total expenditure of the actions studied. Of the 15 drugs / year studied, 14.28% (n = 4) were registered at the National Brazilian Surveillance Agency (ANVISA), were incorporated by the National Commission for the Incorporation of Technologies in SUS (CONITEC) and were part of the List of essential drugs (RENAME); 46.42% (n = 13) were registered with ANVISA, but not incorporated by CONITEC and not members of RENAME; 3.57% (n = 1) registered in ANVISA, incorporated by CONITEC and non-RENAME members and 35.71% (n = 10) without ANVISA registration, not incorporated by CONITEC and not RENAME members. Conclusion: With the Lawsuits to receive free medication, the acquisitions are carried out without planning or establishing minimum criteria, may compromise SUS sustainability.Objetivo: analizar los gastos federales para el sistema público de salud brasileño con medicamentos obtenidos por medio de acciones judiciales entre los años 2011-2014. Metodología: estudio transversal, con características descriptivas y analíticas. Datos levantados en la plataforma DW / COMPRASNET. Resultados de 12.578 procesos de judicialización en la esfera federal fueron extraídos 15 medicamentos con mayor valor de adquisición, de éstos, 7 medicamentos correspondieron a R $ 1,45 mil millones del presupuesto federal lo que significó el 87% del gasto total de las acciones estudiadas. De los 15, 14,28% (n = 4) tenían registro en la Anvisa, estaban incorporados por la Comisión Nacional de Incorporación de Tecnologías en el SUS (CONITEC) y eran integrantes de la Relación de Medicamentos Esenciales (RENAME); 46,42% (n = 13) tenían registro en Anvisa, pero no incorporados por la CONITEC y no integrantes de RENAME; El 3,57% (n = 1) con registro en Anvisa, incorporados por la CONITEC y no integrantes de RENAME y el 35,71% (n = 10) sin registro en la Anvisa, no incorporados por la CONITEC y no integrantes de RENAME. Conclusión: Con la judicialización de la salud las adquisiciones se realizan sin planificación o establecimiento de criterios mínimos lo que puede comprometer la sustentabilidad del SUS.Introdução: Em função da crescente demanda judicialização da saúde no Brasil estima-se que o aumento dos custos pode inviabilizar a sustentabilidade do SUS. Objetivo: analisar os gastos Federais para o sistema público de saúde Brasileiro com medicamentos obtidos por meio de ações judiciais entre os anos de 2011-2014. Metodologia: estudo transversal, com características descritivas e analíticas. Dados levantados na plataforma DW/COMPRASNET. Resultados: De 12.578 processos de judicialização na esfera federal foram extraídos 15 medicamentos com maior valor de aquisição, destes, 7 medicamentos corresponderam a R$ 1,45 bilhão do orçamento federal o que significou 87% do gasto total das ações estudadas. Dos 15, 14,28% (n=4) tinham registro na Anvisa, estavam incorporados pela Comissão Nacional de Incorporação de Tecnologias no SUS (CONITEC) e eram integrantes da Relação de Medicamentos Essenciais (RENAME); 46,42% (n=13) possuíam registro na Anvisa, porém não incorporados pela CONITEC e não integrantes da RENAME; 3,57% (n=1) com registro na Anvisa, incorporados pela CONITEC e não integrantes da RENAME e 35,71% (n=10) sem registro na Anvisa, não incorporados pela CONITEC e não integrantes da RENAME. Conclusão: Com a judicialização da saúde as aquisições são realizadas sem planejamento ou estabelecimento de critérios mínimos o que pode comprometer a sustentabilidade do SUS.  Fundação Oswaldo Cruz Brasília2017-06-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.cadernos.prodisa.fiocruz.br/index.php/cadernos/article/view/38710.17566/ciads.v6i2.387Iberoamerican Journal of Health Law; Vol. 6 No. 2 (2017): (ABR/JUN. 2017); 120-132Cuadernos Iberoamericanos de Derecho Sanitario; Vol. 6 Núm. 2 (2017): (ABR/JUN. 2017); 120-132Cadernos Ibero-Americanos de Direito Sanitário; v. 6 n. 2 (2017): (ABR/JUN. 2017); 120-1322358-18242317-839610.17566/ciads.v6i2reponame:Cadernos Ibero-Americanos de Direito Sanitário (Online)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporhttps://www.cadernos.prodisa.fiocruz.br/index.php/cadernos/article/view/387/460Copyright (c) 2017 CADERNOS IBERO-AMERICANOS DE DIREITO SANITÁRIOinfo:eu-repo/semantics/openAccessNogueira, Karina PiresCamargo, Erika Barbosa2020-03-24T21:04:41Zoai:ojs.cadernos.prodisa.fiocruz.br:article/387Revistahttp://www.cadernos.prodisa.fiocruz.brPUBhttp://www.cadernos.prodisa.fiocruz.br/index.php/cadernos/oaicadernos.direitosanitario@fiocruz.br2358-18242317-8396opendoar:2020-03-24T21:04:41Cadernos Ibero-Americanos de Direito Sanitário (Online) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.none.fl_str_mv Lawsuits to receive free medication: Federal expenditures for the Brazilian Public Health System (SUS) between 2011-2014
Judicialización de la salud: gastos Federales para el Sistema Público de Salud entre 2011-2014
Judicialização da saúde: gastos Federais para o Sistema Único de Saúde (SUS) entre 2011-2014
title Lawsuits to receive free medication: Federal expenditures for the Brazilian Public Health System (SUS) between 2011-2014
spellingShingle Lawsuits to receive free medication: Federal expenditures for the Brazilian Public Health System (SUS) between 2011-2014
Nogueira, Karina Pires
Judicialização
Decisões judiciais
Direito à saúde
Judicialization
Judge Decisions
Right to Health
Judicialización
Decisiones judiciales
Derecho a la salud
title_short Lawsuits to receive free medication: Federal expenditures for the Brazilian Public Health System (SUS) between 2011-2014
title_full Lawsuits to receive free medication: Federal expenditures for the Brazilian Public Health System (SUS) between 2011-2014
title_fullStr Lawsuits to receive free medication: Federal expenditures for the Brazilian Public Health System (SUS) between 2011-2014
title_full_unstemmed Lawsuits to receive free medication: Federal expenditures for the Brazilian Public Health System (SUS) between 2011-2014
title_sort Lawsuits to receive free medication: Federal expenditures for the Brazilian Public Health System (SUS) between 2011-2014
author Nogueira, Karina Pires
author_facet Nogueira, Karina Pires
Camargo, Erika Barbosa
author_role author
author2 Camargo, Erika Barbosa
author2_role author
dc.contributor.author.fl_str_mv Nogueira, Karina Pires
Camargo, Erika Barbosa
dc.subject.por.fl_str_mv Judicialização
Decisões judiciais
Direito à saúde
Judicialization
Judge Decisions
Right to Health
Judicialización
Decisiones judiciales
Derecho a la salud
topic Judicialização
Decisões judiciais
Direito à saúde
Judicialization
Judge Decisions
Right to Health
Judicialización
Decisiones judiciales
Derecho a la salud
description Objective To analyze Federal expenditures for the Brazilian public health system with drugs obtained through lawsuits between the years 2011-2014. Methods: cross-sectional study, with descriptive and analytical characteristics. Data collected from the DW / COMPRASNET platform. Results: In total 12,578 lawsuits were identified at the federal level and 15 drugs with the highest acquisition value were extracted. Of these, seven drugs corresponded to US$ 452.644.065.68 million dollars of the federal budget, which represented 87% of the total expenditure of the actions studied. Of the 15 drugs / year studied, 14.28% (n = 4) were registered at the National Brazilian Surveillance Agency (ANVISA), were incorporated by the National Commission for the Incorporation of Technologies in SUS (CONITEC) and were part of the List of essential drugs (RENAME); 46.42% (n = 13) were registered with ANVISA, but not incorporated by CONITEC and not members of RENAME; 3.57% (n = 1) registered in ANVISA, incorporated by CONITEC and non-RENAME members and 35.71% (n = 10) without ANVISA registration, not incorporated by CONITEC and not RENAME members. Conclusion: With the Lawsuits to receive free medication, the acquisitions are carried out without planning or establishing minimum criteria, may compromise SUS sustainability.
publishDate 2017
dc.date.none.fl_str_mv 2017-06-29
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.cadernos.prodisa.fiocruz.br/index.php/cadernos/article/view/387
10.17566/ciads.v6i2.387
url https://www.cadernos.prodisa.fiocruz.br/index.php/cadernos/article/view/387
identifier_str_mv 10.17566/ciads.v6i2.387
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://www.cadernos.prodisa.fiocruz.br/index.php/cadernos/article/view/387/460
dc.rights.driver.fl_str_mv Copyright (c) 2017 CADERNOS IBERO-AMERICANOS DE DIREITO SANITÁRIO
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2017 CADERNOS IBERO-AMERICANOS DE DIREITO SANITÁRIO
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Fundação Oswaldo Cruz Brasília
publisher.none.fl_str_mv Fundação Oswaldo Cruz Brasília
dc.source.none.fl_str_mv Iberoamerican Journal of Health Law; Vol. 6 No. 2 (2017): (ABR/JUN. 2017); 120-132
Cuadernos Iberoamericanos de Derecho Sanitario; Vol. 6 Núm. 2 (2017): (ABR/JUN. 2017); 120-132
Cadernos Ibero-Americanos de Direito Sanitário; v. 6 n. 2 (2017): (ABR/JUN. 2017); 120-132
2358-1824
2317-8396
10.17566/ciads.v6i2
reponame:Cadernos Ibero-Americanos de Direito Sanitário (Online)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Cadernos Ibero-Americanos de Direito Sanitário (Online)
collection Cadernos Ibero-Americanos de Direito Sanitário (Online)
repository.name.fl_str_mv Cadernos Ibero-Americanos de Direito Sanitário (Online) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv cadernos.direitosanitario@fiocruz.br
_version_ 1798942494157701120

Registros relacionados